Literature DB >> 33893623

The Road Ahead for Circulating microRNAs in Diagnosis and Management of Testicular Germ Cell Tumors.

John T Lafin1, Matthew J Murray2,3, Nicholas Coleman2,4, A Lindsay Frazier5, James F Amatruda6,7,8, Aditya Bagrodia9.   

Abstract

Entities:  

Year:  2021        PMID： 33893623     DOI： 10.1007/s40291-021-00526-6

Source DB:  PubMed          Journal:  Mol Diagn Ther        ISSN： 1177-1062            Impact factor:   4.074


× No keyword cloud information.
  15 in total

1.  American Society of Clinical Oncology Clinical Practice Guideline on uses of serum tumor markers in adult males with germ cell tumors.

Authors:  Timothy D Gilligan; Jerome Seidenfeld; Ethan M Basch; Lawrence H Einhorn; Timothy Fancher; David C Smith; Andrew J Stephenson; David J Vaughn; Roxanne Cosby; Daniel F Hayes
Journal:  J Clin Oncol       Date:  2010-06-07       Impact factor: 44.544

2.  MicroRNAs: Turning the Tide in Testicular Cancer.

Authors:  Nirmish Singla; John T Lafin; Aditya Bagrodia
Journal:  Eur Urol       Date:  2019-06-21       Impact factor: 20.096

3.  Serum MicroRNA-371a-3p Levels Predict Viable Germ Cell Tumor in Chemotherapy-naïve Patients Undergoing Retroperitoneal Lymph Node Dissection.

Authors:  John T Lafin; Nirmish Singla; Solomon L Woldu; Yair Lotan; Cheryl M Lewis; Kuntal Majmudar; Anna Savelyeva; Payal Kapur; Vitaly Margulis; Douglas W Strand; Matthew J Murray; James F Amatruda; Aditya Bagrodia
Journal:  Eur Urol       Date:  2019-11-05       Impact factor: 20.096

4.  Retroperitoneal metastases in testicular cancer: role of CT measurements of residual masses in decision making for resection after chemotherapy.

Authors:  E W Steyerberg; H J Keizer; D T Sleijfer; S D Fossâ; D F Bajorin; A Gerl; R de Wit; W J Kirkels; H S Koops; J D Habbema
Journal:  Radiology       Date:  2000-05       Impact factor: 11.105

Review 5.  Serum tumor markers in the evaluation of male germ cell tumors.

Authors:  LaMont J Barlow; Gina M Badalato; James M McKiernan
Journal:  Nat Rev Urol       Date:  2010-11       Impact factor: 14.432

6.  The Novel Biomarker of Germ Cell Tumours, Micro-RNA-371a-3p, Has a Very Rapid Decay in Patients with Clinical Stage 1.

Authors:  Arlo Radtke; Finja Hennig; Raphael Ikogho; Johannes Hammel; Petra Anheuser; Christian Wülfing; Gazanfer Belge; Klaus-Peter Dieckmann
Journal:  Urol Int       Date:  2018-04-26       Impact factor: 2.089

7.  Serum miRNA Predicts Viable Disease after Chemotherapy in Patients with Testicular Nonseminoma Germ Cell Tumor.

Authors:  Ricardo Leão; Ton van Agthoven; Arnaldo Figueiredo; Michael A S Jewett; Kamel Fadaak; Joan Sweet; Ardalan E Ahmad; Lynn Anson-Cartwright; Peter Chung; Aaron Hansen; Padraig Warde; Pedro Castelo-Branco; Martin O'Malley; Philippe L Bedard; Leendert H J Looijenga; Robert J Hamilton
Journal:  J Urol       Date:  2018-02-21       Impact factor: 7.450

8.  Utility of Serum miR-371a-3p in Predicting Relapse on Surveillance in Patients with Clinical Stage I Testicular Germ Cell Cancer.

Authors:  João Lobo; Ricardo Leão; Ad J M Gillis; Annette van den Berg; Lynn Anson-Cartwright; Eshetu G Atenafu; Kopika Kuhathaas; Peter Chung; Aaron Hansen; Philippe L Bedard; Michael A S Jewett; Padraig Warde; Martin O'Malley; Joan Sweet; Leendert H J Looijenga; Robert J Hamilton
Journal:  Eur Urol Oncol       Date:  2020-12-04

9.  Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study.

Authors:  Klaus-Peter Dieckmann; Arlo Radtke; Lajos Geczi; Cord Matthies; Petra Anheuser; Ulrike Eckardt; Jörg Sommer; Friedemann Zengerling; Emanuela Trenti; Renate Pichler; Hanjo Belz; Stefan Zastrow; Alexander Winter; Sebastian Melchior; Johannes Hammel; Jennifer Kranz; Marius Bolten; Susanne Krege; Björn Haben; Wolfgang Loidl; Christian Guido Ruf; Julia Heinzelbecker; Axel Heidenreich; Jann Frederik Cremers; Christoph Oing; Thomas Hermanns; Christian Daniel Fankhauser; Silke Gillessen; Hermann Reichegger; Richard Cathomas; Martin Pichler; Marcus Hentrich; Klaus Eredics; Anja Lorch; Christian Wülfing; Sven Peine; Werner Wosniok; Carsten Bokemeyer; Gazanfer Belge
Journal:  J Clin Oncol       Date:  2019-03-15       Impact factor: 44.544

10.  Serum Tumour Markers in Testicular Germ Cell Tumours: Frequencies of Elevated Levels and Extents of Marker Elevation Are Significantly Associated with Clinical Parameters and with Response to Treatment.

Authors:  Klaus-Peter Dieckmann; Hanna Simonsen-Richter; Magdalena Kulejewski; Petra Anheuser; Henrik Zecha; Hendrik Isbarn; Uwe Pichlmeier
Journal:  Biomed Res Int       Date:  2019-05-28       Impact factor: 3.411
View more
  3 in total

Review 1.  Advancing clinical and translational research in germ cell tumours (GCT): recommendations from the Malignant Germ Cell International Consortium.

Authors:  Adriana Fonseca; João Lobo; Florette K Hazard; Joanna Gell; Peter K Nicholls; Robert S Weiss; Lindsay Klosterkemper; Samuel L Volchenboum; James C Nicholson; A Lindsay Frazier; James F Amatruda; Aditya Bagrodia; Michelle Lockley; Matthew J Murray
Journal:  Br J Cancer       Date:  2022-10-13       Impact factor: 9.075

Review 2.  The utility of cfDNA in TGCT patient management: a systematic review.

Authors:  Jure Krasic; Lucija Skara; Ana Katusic Bojanac; Monika Ulamec; Davor Jezek; Tomislav Kulis; Nino Sincic
Journal:  Ther Adv Med Oncol       Date:  2022-05-25       Impact factor: 5.485

3.  DigiMir Test: Establishing a Novel Pipeline for MiR-371a Quantification Using Droplet Digital PCR in Liquid Biopsies From Testicular Germ Cell Tumor Patients.

Authors:  José Pedro Sequeira; João Lobo; Vera Constâncio; Tiago Brito-Rocha; Carina Carvalho-Maia; Isaac Braga; Joaquina Maurício; Rui Henrique; Carmen Jerónimo
Journal:  Front Oncol       Date:  2022-06-10       Impact factor: 5.738
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.